Publicações

Bicalutamide (Casodex) 150 Mg plus Standard Care in Early Non-Metastatic Prostate Cancer: Results from Early Prostate Cancer Trial 24 at a Median 7 Years' Follow-Up

AuthID
P-004-BNY

Author(s)

Wirth, M

Tyrrell, C

Delaere, K

Sanchez Chapado, M

Ramon, J

Wallace, DMA

Hetherington, J

Pina, F

Heyns, CF

Navani, S

Armstrong, J

Group Author(s)

CASODEX Early Prostate Canc Triali

Tipo de Documento

Article

Year published

2007

Publicado

in PROSTATE CANCER AND PROSTATIC DISEASES, ISSN: 1365-7852

Volume: 10, Número: 1, Páginas: 87-93 (7)

Indexing

Wos^®

Scopus^®

Crossref^®

Pubmed^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1038/sj.pcan.4500916

Pubmed: 17102802

SCOPUS: 2-s2.0-33847609549

Wos: WOS:000244604800013

Source Identifiers

ISSN: 1365-7852

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Bicalutamide (Casodex) 150 Mg plus Standard Care in Early Non-Metastatic Prostate Cancer: Results from Early Prostate Cancer Trial 24 at a Median 7 Years' Follow-Up

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Bicalutamide (Casodex) 150 Mg plus Standard Care in Early Non-Metastatic Prostate Cancer: Results from Early Prostate Cancer Trial 24 at a Median 7 Years' Follow-Up

Links Úteis

Ajuda